Exalys Therapeutics is focused on the development of first-in-class therapies for the treatment of inflammatory disorders.
Jul 16, 2020 · Exalys Therapeutics is focused on developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range ...
Jul 28, 2020 · Exalys Therapeutics, a new San Diego bitotech startup, has raised $15 million in Series A financing from Domain Associates and Catalys ...
Exalys Company Profile: Valuation, Funding & Investors | PitchBook
pitchbook.com › profiles › company
Developer of novel anti-inflammatory therapeutics designed for the treatment of inflammatory disorders including pain and renal dysfunction. The company is ...
Jul 16, 2020 · Exalys Therapeutics is focused on developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range ...
Mar 9, 2024 · Developer of therapeutic solutions for treating neuroinflammatory disorders. The company's next-generation EP4 receptor antagonists are used ...
Exalys Therapeutics develops novel anti-inflammatory therapeutics intended for the treatment of inflammatory disorders including pain and renal dysfunction.
Exalys Therapeutics is focused on the development of first-in-class therapies for the treatment of inflammatory disorders.
This is a non-profit endeavour to address the absence of a comprehensive, unbiased, and independent bibliographic database. The project is absolutely ...
Exalys Therapeutics// Exalys Therapeutics is developing a portfolio of novel anti-inflammatory therapeutics with best-in-class properties to target a range ...